Dna X (SONM) Change in Accured Expenses (2018 - 2026)

Dna X (SONM) has 9 years of Change in Accured Expenses data on file, last reported at -$1.3 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 490.83% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.0 million (down 136.99% YoY) and the FY2025 annual result came in at -$2.0 million, down 124.47% from the prior year.
• Change in Accured Expenses rose to -$1.3 million in Q1 2026, from -$1.9 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $9.8 million in Q3 2024 to a low of -$2.8 million in Q4 2024.
• A 5-year average of $338058.8 and a median of $81000.0 in 2022 frame the typical range for Change in Accured Expenses.
• The widest YoY moves for Change in Accured Expenses: up 1886.42% in 2023, down 778.1% in 2023.
• Tracing SONM's Change in Accured Expenses over 5 years: stood at $81000.0 in 2022, then jumped by 1886.42% to $1.6 million in 2023, then slumped by 275.7% to -$2.8 million in 2024, then jumped by 31.66% to -$1.9 million in 2025, then jumped by 33.33% to -$1.3 million in 2026.
• The last three Change in Accured Expenses figures came in at -$1.3 million (Q1 2026), -$1.9 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.